Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Nov 10;60(4):505–513. doi: 10.1093/cid/ciu867

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

PMC Copyright notice

Figure 1. — Study design and major findings. Flowchart indicates number of subjects screened and included in the study. Thirty-six of 159 subjects had antibody to hepatitis B surface antigen (anti-HBs) levels <12 mIU/mL (group 1, 9/50 [18%]; group 2, 13/50 [26%]; and group 3, 14/59 [24%]). Thirty-four of 36 received a booster vaccine (group 1, 8/9 [88%]; group 2, 12/13 [92%]; and group 3, 14/14 [100%]). Thirty-two of 34 developed protective levels of anti-HBs 3 weeks after the booster vaccine (group 1, 7/8 [86%]; group 2, 11/12 [92%]; and group 3, 14/14 [100%]). Abbreviation: HBV, hepatitis B virus.